Catalyst Wire Dossier Catalyst Wire Dossier

APHEXDA

motixafortide · Gamida Cell Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for APHEXDA, covering 2023-09-08 to 2026-03-11. Get the full timeline:

Most recent: FDA Approved: APHEXDA — Supplemental Application (Gamida Cell Inc.)

See pricing